Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6445 Main Street
OPC 24
Houston, TX 77030Phone+1 713-441-9948Fax+1 713-441-8791
Education & Training
Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
Novant Health New Hanover Regional Medical CenterResidency, Internal Medicine, 2007 - 2008
Hunan Medical UniversityClass of 1992
Certifications & Licensure
TX State Medical License 2012 - 2025
NC State Medical License 2007 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors Start of enrollment: 2020 Dec 14
Roles: Contact
- Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy Start of enrollment: 2021 Oct 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience.Sanjana Ranganathan, Carlos Riveros, Jiaqiong Xu, Siqi Hu, Michael Geng
Urologic Oncology. 2024-09-01 - 1 citations5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer.Jianming Shao, Yitian Xu, Randall J Olsen, Saro Kasparian, Kai Sun
Cells. 2024-04-19 - 4 citationsA Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer.Jian Guan, Kai Sun, Carlo A Guerrero, Junjun Zheng, Yitian Xu
International Journal of Radiation Oncology, Biology, Physics. 2024-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
